Tesamorelin 10mg-20mg

Potent GHRH analog and the only peptide in this class FDA-approved for reducing visceral adiposity in patients with HIV-associated lipodystrophy. It promotes GH and IGF-1 release, leading to reduced abdominal fat and improved body composition, while preserving lean muscle mass.

IMPORTANT AUSTRALIAN COMPLIANCE DISCLAIMER

This material is supplied for laboratory research purposes only.
Tesamorelin is not approved by the Therapeutic Goods Administration (TGA) for human or veterinary use. Nothing in this document is intended to provide, nor should it be interpreted as, medical advice, dosing guidance, or instructions for administration to any person or animal.

The supplier and author accept no liability for misuse, off-label application, or reliance on this material outside its intended research context.